Patient Characteristics Associated With the Choice of Triple Antithrombotic Therapy in Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Patient Characteristics Associated With the Choice of Triple Antithrombotic Therapy in Acute Coronary Syndromes

Published:2009-11 Issue:9 Volume:104 Page:1171-1178
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Depta Jeremiah P.,Cannon Christopher P.,Fonarow Gregg C.,Zhao Xin,Peacock W. Frank,Bhatt Deepak L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance;Depta;Am J Cardiovasc Drugs,2008

2. Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials;Helton;Am J Cardiovasc Drugs,2007

3. Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Anderson;J Am Coll Cardiol,2007

4. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;King;J Am Coll Cardiol,2008

5. Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Antman;J Am Coll Cardiol,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation and ischemic heart disease: (un)solved therapeutic dilemma?;Minerva Cardiology and Angiology;2023-10

2. Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice;Pharmaceutics;2022-05-24

3. Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention;Rational Pharmacotherapy in Cardiology;2021-09-03

4. Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial;JACC: Cardiovascular Interventions;2021-04

5. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease;Journal of the American College of Cardiology;2021-02